Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

7,977 public trials 716 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

Comprehensive Add on Study in Japan

NCT01204294

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • 1218.78.008 Boehringer Ingelheim Investigational Site Akishima, Tokyo, Japan
  • 1218.78.030 Boehringer Ingelheim Investigational Site Amagasaki, Hyogo, Japan
  • 1218.78.017 Boehringer Ingelheim Investigational Site Annaka, Gunma, Japan
  • 1218.78.006 Boehringer Ingelheim Investigational Site Aomori, Aomori, Japan
View all 43 locations
View Trial Details
Completed

Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone

NCT00996658

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • 1218.61.01028 Boehringer Ingelheim Investigational Site Escondido, California, United States
  • 1218.61.01014 Boehringer Ingelheim Investigational Site Greenbrae, California, United States
  • 1218.61.01015 Boehringer Ingelheim Investigational Site Los Angeles, California, United States
  • 1218.61.01042 Boehringer Ingelheim Investigational Site Paramount, California, United States
View all 52 locations
View Trial Details
Completed

Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy

NCT01474538

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Little Rock, Arkansas, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jacksonville, Florida, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. West Palm Beach, Florida, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Atlanta, Georgia, United States
View Trial Details
Completed

Efficacy, Safety and Satisfaction of the New Pen Needle 33 Gauge x 4 mm.

NCT01745549

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +8 more
Locations
  • UO Malattie Metaboliche e Diabetologia - Ospedale di Treviglio-Caravaggio Treviglio, BG, Italy
  • UO Diabetologia per Trattamento e Educazione dei Diabetici - Spedali Civili di Brescia Brescia, BS, Italy
  • U.O.S. Diabetologia e Malattie Metaboliche - PO Cantù - Mariano Comense Mariano Comense, CO, Italy
  • Struttura Complessa Dietologia-Diabetologia Malattie Metaboliche - Ospedale Pertini Roma, RM, Italy
View Trial Details
Completed

Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes Patients

NCT00328172

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • 1218.5.10020 Boehringer Ingelheim Investigational Site Chula Vista, California, United States
  • 1218.5.10001 Boehringer Ingelheim Investigational Site La Jolla, California, United States
  • 1218.5.10007 Boehringer Ingelheim Investigational Site Walnut Creek, California, United States
  • 1218.5.10041 Boehringer Ingelheim Investigational Site Denver, Colorado, United States
View all 71 locations
View Trial Details

Related conditions